Cargando…

Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying

Continuous manufacturing (CM) is a promising strategy to achieve various benefits in the context of quality, flexibility, safety and cost in pharmaceutical production. One of the main technical challenges of CM is that the process needs to handle transient conditions such as the start-up phase befor...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauli, Victoria, Kleinebudde, Peter, Krumme, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022419/
https://www.ncbi.nlm.nih.gov/pubmed/31952206
http://dx.doi.org/10.3390/pharmaceutics12010067
_version_ 1783498011281719296
author Pauli, Victoria
Kleinebudde, Peter
Krumme, Markus
author_facet Pauli, Victoria
Kleinebudde, Peter
Krumme, Markus
author_sort Pauli, Victoria
collection PubMed
description Continuous manufacturing (CM) is a promising strategy to achieve various benefits in the context of quality, flexibility, safety and cost in pharmaceutical production. One of the main technical challenges of CM is that the process needs to handle transient conditions such as the start-up phase before state of control operation is reached, which can potentially cause out-of-specification (OOS) material. In this context, the presented paper aims to demonstrate that suitable process control strategies during start-up of a continuous granulation and drying operation can limit or even avoid OOS material production and hence can ensure that the provided benefits of CM are not compromised by poor production yields. In detail, heat-up of the drying chamber prior the start of production can lead to thermal energy being stored inside of the stainless-steel housing, acting as an energy buffer that is known to cause over-dried granules in the first few minutes of the drying process. To compensate this issue, an automatic ramping procedure of dryer rotation speed (and hence drying time) was introduced into the plant’s process control system, which counteracts the excessive drying capacity during start-up. As a result, dry granules exiting the dryer complied with the targeted intermediate critical quality attribute loss-on-drying (LOD) from the very beginning of production.
format Online
Article
Text
id pubmed-7022419
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70224192020-03-09 Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying Pauli, Victoria Kleinebudde, Peter Krumme, Markus Pharmaceutics Article Continuous manufacturing (CM) is a promising strategy to achieve various benefits in the context of quality, flexibility, safety and cost in pharmaceutical production. One of the main technical challenges of CM is that the process needs to handle transient conditions such as the start-up phase before state of control operation is reached, which can potentially cause out-of-specification (OOS) material. In this context, the presented paper aims to demonstrate that suitable process control strategies during start-up of a continuous granulation and drying operation can limit or even avoid OOS material production and hence can ensure that the provided benefits of CM are not compromised by poor production yields. In detail, heat-up of the drying chamber prior the start of production can lead to thermal energy being stored inside of the stainless-steel housing, acting as an energy buffer that is known to cause over-dried granules in the first few minutes of the drying process. To compensate this issue, an automatic ramping procedure of dryer rotation speed (and hence drying time) was introduced into the plant’s process control system, which counteracts the excessive drying capacity during start-up. As a result, dry granules exiting the dryer complied with the targeted intermediate critical quality attribute loss-on-drying (LOD) from the very beginning of production. MDPI 2020-01-15 /pmc/articles/PMC7022419/ /pubmed/31952206 http://dx.doi.org/10.3390/pharmaceutics12010067 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pauli, Victoria
Kleinebudde, Peter
Krumme, Markus
Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_full Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_fullStr Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_full_unstemmed Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_short Predictive Model-Based Process Start-Up in Pharmaceutical Continuous Granulation and Drying
title_sort predictive model-based process start-up in pharmaceutical continuous granulation and drying
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022419/
https://www.ncbi.nlm.nih.gov/pubmed/31952206
http://dx.doi.org/10.3390/pharmaceutics12010067
work_keys_str_mv AT paulivictoria predictivemodelbasedprocessstartupinpharmaceuticalcontinuousgranulationanddrying
AT kleinebuddepeter predictivemodelbasedprocessstartupinpharmaceuticalcontinuousgranulationanddrying
AT krummemarkus predictivemodelbasedprocessstartupinpharmaceuticalcontinuousgranulationanddrying